发明名称 |
Method Of Fabricating An Implantable Medical Device Comprising A Rapamycin Derivative |
摘要 |
This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount. |
申请公布号 |
US2014250836(A1) |
申请公布日期 |
2014.09.11 |
申请号 |
US201313789473 |
申请日期 |
2013.03.07 |
申请人 |
ABBOTT CARDIOVASCULAR SYSTEMS INC. |
发明人 |
Pacetti Stephen D.;Fox Julia |
分类号 |
A61L31/08;B65B55/12;A61L31/16 |
主分类号 |
A61L31/08 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of fabricating an implantable medical device comprising a rapamycin derivative drug, the method comprising:
synthesizing a rapamycin derivative drug; purifying the rapamycin derivative drug using a technique that results in substantially pure rapamycin derivative drug dissolved in a solvent, wherein:
the solvent used in the purification technique is suitable for preparation of a coating composition comprising the rapamycin derivative drug; determining the percent by weight of the rapamycin derivative in the solvent; adjusting the amount of solvent such that the weight percent rapamycin derivative drug in the solvent is that desired in a coating composition to be applied to an implantable medical device; adding a desired weight percent, based on the weight of rapamycin derivative drug, of an pharmaceutically acceptable antioxidant stabilizer to form the coating composition; and disposing the coating composition on the implantable medical device to form a drug reservoir layer. |
地址 |
Santa Clara CA US |